28.06.2016 Views

Neuropsychiatric Symptoms of Epilepsy

5qIFB7UWr

5qIFB7UWr

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Chapter 4<br />

Anxiety<br />

Christian Brandt<br />

Abstract Anxiety disorders constitute important, though for a long time, neglected<br />

comorbidities <strong>of</strong> epilepsy. They deserve attention, because they are frequent and<br />

negatively impact the quality <strong>of</strong> life <strong>of</strong> persons with epilepsy. This chapter covers<br />

aspects <strong>of</strong> the neurobiological and pathophysiological correlates <strong>of</strong> anxiety and<br />

anxiety disorders, classification and differential diagnosis <strong>of</strong> epilepsy-related anxiety,<br />

epidemiology, the relationship between anxiety and different forms <strong>of</strong> epilepsy,<br />

and the influence <strong>of</strong> epilepsy surgery on concomitant anxiety. The bidirectional<br />

relationship between epilepsy and anxiety deserves broad attention, as this extends<br />

to the different levels <strong>of</strong> this comorbidity from animal models (for instance, GAERS<br />

rats may show increased levels <strong>of</strong> anxiety when compared to healthy controls,<br />

already before the onset <strong>of</strong> epilepsy) to epidemiology (anxiety may be detected up<br />

to 3 years before epilepsy diagnosis). Treatment (drugs, psychotherapy, alternative<br />

treatments) is also covered. Selective serotonin-reuptake inhibitors and serotoninnoradrenalin<br />

reuptake inhibitors are established in the treatment <strong>of</strong> anxiety disorders.<br />

It would be <strong>of</strong> value in persons with epilepsy and a comorbid anxiety disorder<br />

to treat both conditions with a single drug, which leads to the issue <strong>of</strong> anxiolytic<br />

properties <strong>of</strong> antiepileptic drugs (AEDs). Strong evidence has been demonstrated<br />

for pregabalin in social phobia and generalized anxiety disorder, lamotrigine in<br />

posttraumatic stress disorder, and gabapentin in social anxiety. Anxiety may also be<br />

a side effect <strong>of</strong> AEDs. Case vignettes at the end <strong>of</strong> the chapter illustrate the issue.<br />

Keywords <strong>Epilepsy</strong> • Anxiety • Epidemiology • Prevalence • Bidirectional<br />

Relationship • Antiepileptic Drugs • Pregabalin • Animal Models • Quality Of Life<br />

C. Brandt , MD<br />

Department <strong>of</strong> General Epileptology , Bethel <strong>Epilepsy</strong> Centre ,<br />

Maraweg 21 , Bielefeld 33617 , Germany<br />

e-mail: christian.brandt@mara.de<br />

© Springer International Publishing Switzerland 2016<br />

M. Mula (ed.), <strong>Neuropsychiatric</strong> <strong>Symptoms</strong> <strong>of</strong> <strong>Epilepsy</strong>, <strong>Neuropsychiatric</strong><br />

<strong>Symptoms</strong> <strong>of</strong> Neurological Disease, DOI 10.1007/978-3-319-22159-5_4<br />

53

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!